fingolimod hydrochloride has been researched along with dinoprostone in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 29,105 | 1,346 | 6,357 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | dinoprostone (IC50) |
---|---|---|---|
Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imado, T; Iwasaki, T; Kitano, S; Miyazawa, K; Sano, H; Tsunemi, S | 1 |
Guerrero, M; Kays, J; Li, C; Li, JN; Nicol, GD | 1 |
2 other study(ies) available for fingolimod hydrochloride and dinoprostone
Article | Year |
---|---|
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
Topics: Administration, Oral; Animals; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Cell Line; Cytokines; Dinoprostone; Disease Models, Animal; Female; Fingolimod Hydrochloride; Glucans; Humans; Immunosuppressive Agents; Interleukin-4; Mice; Mice, Inbred Strains; Polysaccharides; Propylene Glycols; Specific Pathogen-Free Organisms; Sphingosine; Spleen; Thymus Gland | 2010 |
Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Topics: Action Potentials; Anilides; Animals; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Fingolimod Hydrochloride; Ganglia, Spinal; Gene Expression Regulation; Immunosuppressive Agents; Lysophospholipids; Mice; Mice, Inbred C57BL; Organophosphonates; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Sensory Receptor Cells; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazolidines | 2015 |